Literature DB >> 16959613

Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.

Sourav Ghosh1, Vinay Tergaonkar, Carla V Rothlin, Ricardo G Correa, Virginie Bottero, Pradeep Bist, Inder M Verma, Tony Hunter.   

Abstract

The TSC1-TSC2 complex has recently been implicated in cell survival responses. We observed that NF-kappaB signaling is attenuated in TSC1- and TSC2-deficient MEFs concomitant with reduced survival following DNA damage or TNFalpha stimulation. Reconstitution of TSC2 expression in TSC2(-/-) MEFs rescued survival in an NF-kappaB activity-dependent manner. Furthermore, in TSC2(-/-) MEFs, the rapamycin-mediated inhibition of deregulated mTOR activity restored NF-kappaB activation and survival. This rapamycin-mediated effect was reversed by inhibition of NF-kappaB transcriptional activation or by inhibition of ERK1/2 MAP kinase or PI-3K pathways, which lie on signaling cascades that lead to NF-kappaB activation. These results provide evidence for a crosstalk between the TSC/Rheb/mTOR pathway and the NF-kappaB induction pathways and indicate that NF-kappaB functions as an important survival factor that regulates TSC2-dependent cell survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959613     DOI: 10.1016/j.ccr.2006.08.007

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  59 in total

1.  Cdc6 protein obstructs apoptosome assembly and consequent cell death by forming stable complexes with activated Apaf-1 molecules.

Authors:  Shinichiro Niimi; Shiho Arakawa-Takeuchi; Baasanjav Uranbileg; Jun-ha Park; Shigeki Jinno; Hiroto Okayama
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

2.  Differential IKK/NF-κB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous Sclerosis Complex Tumor Cells.

Authors:  Yu Gao; Ronald B Gartenhaus; Rena G Lapidus; Arif Hussain; Yanting Zhang; Xinghuan Wang; Han C Dan
Journal:  Mol Cancer Res       Date:  2015-09-15       Impact factor: 5.852

3.  TBK1 regulates prostate cancer dormancy through mTOR inhibition.

Authors:  Jin Koo Kim; Younghun Jung; Jingcheng Wang; Jeena Joseph; Anjali Mishra; Elliott E Hill; Paul H Krebsbach; Kenneth J Pienta; Yusuke Shiozawa; Russell S Taichman
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

4.  WIP1 phosphatase is a negative regulator of NF-kappaB signalling.

Authors:  Joanne Chew; Subhra Biswas; Sathyavageeswaran Shreeram; Mahathir Humaidi; Ee Tsin Wong; Manprit Kaur Dhillion; Hsiangling Teo; Amit Hazra; Cheok Chit Fang; Eduardo López-Collazo; Dmitry V Bulavin; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2009-04-19       Impact factor: 28.824

Review 5.  AMPK: An emerging target for modification of injury-induced pain plasticity.

Authors:  Theodore J Price; Gregory Dussor
Journal:  Neurosci Lett       Date:  2013-07-03       Impact factor: 3.046

Review 6.  Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Authors:  N Misaghian; G Ligresti; L S Steelman; F E Bertrand; J Bäsecke; M Libra; F Nicoletti; F Stivala; M Milella; A Tafuri; M Cervello; A M Martelli; J A McCubrey
Journal:  Leukemia       Date:  2008-09-18       Impact factor: 11.528

Review 7.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

8.  Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin.

Authors:  Itzamarie Chévere-Torres; Jordan M Maki; Emanuela Santini; Eric Klann
Journal:  Neurobiol Dis       Date:  2011-07-30       Impact factor: 5.996

9.  Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response.

Authors:  Sricharan Bandhakavi; Young-Mi Kim; Seung-Hyun Ro; Hongwei Xie; Getiria Onsongo; Chang-Bong Jun; Do-Hyung Kim; Timothy J Griffin
Journal:  Mol Cell Proteomics       Date:  2009-11-23       Impact factor: 5.911

10.  Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.

Authors:  Dong Bai; Lynn Ueno; Peter K Vogt
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.